loadpatents
Patent applications and USPTO patent grants for Elan Pharmaceuticals.The latest application filed is for "heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4".
Patent | Date |
---|---|
Compounds to treat Alzheimer's disease Grant 7,214,715 - Beck , et al. May 8, 2 | 2007-05-08 |
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20070099921 - Konradi; Andrei W. ;   et al. | 2007-05-03 |
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20050203093 - Konradi, Andrei W. ;   et al. | 2005-09-15 |
Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease App 20050159460 - Varghese, John | 2005-07-21 |
Test and model for Alzheimer's disease App 20030165958 - Hardy, John Anthony ;   et al. | 2003-09-04 |
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein Grant 6,018,024 - Seubert , et al. January 25, 2 | 2000-01-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.